ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

Nutrition RFPs Will Really Be Grants, Gori Says

January 23, 1976

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20%

February 2, 1990